Donate to Illuminate Order Brochures Contact TSF
Facebook Logo Twitter Logo Youtube Logo Instagram Logo LinkedIn Logo TikTok Logo Blue Sky Logo

Archives: Research Summaries

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks 

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks 

Journal: Journal of Neurology, Neurosurgery & Psychiatry; November 4, 2024

Author(s): Carolin Schwake, Theodoros Ladopoulos, Vivien Häußler, Ingo Kleiter, Marius Ringelstein, Orhan Aktas, Tania Kümpfel, Daniel Engels, Joachim Havla, Martin W Hümmert, Julian Reza Kretschmer, Daria Tkachenko, Corinna Trebst, Ana Beatriz Ayroza Galvão Ribeiro Gomes, Anne-Katrin Pröbstel, Mirjam Korporal-Kuhnke, Brigitte Wildemann, Sven Jarius, Refik Pul, Mosche Pompsch, Markus Krämer, Florian Then Bergh, Clemens Gödel, Patricia Schwarz, Markus C Kowarik, Paulus Stefan Rommer, Ioannis Vardakas, Makbule Senel, Alexander Winkelmann, Nele Retzlaff, Martin S Weber, Leila Husseini, Annette Walter, Patrick Schindler, Judith Bellmann-Strobl, Friedemann Paul, Ralf Gold, Ilya Ayzenberg, Neuromyelitis Optica Study Group (NEMOS)

How effective are blood-filtering treatments like plasma exchange for MOGAD?


Real-Life Evaluation of the MOGAD Diagnostic Criteria

Real-Life Evaluation of the MOGAD Diagnostic Criteria

Journal: Neurology Neuroimmunology & Neuroinflammation; August 19, 2025

Author(s): Sara Carta, Elia Sechi Alessandro Dinoto, Chiara Mancinelli, Giacomo Greco, Giorgia Teresa Maniscalco Sara Cornacchini, Maria Pia Giannoccaro, Francesca Calabria, Alessandro Marziali, Stefano Masciocchi, Mario Risi, Alberto Cossu, Irene Volonghi, Gaetano Cantalupo, Marco Zoccarato, Riccardo Orlandi, Elisabetta Del Zotto, Diana Ferraro, Milena Trentinaglia, Stefano De Biase, Luisa Grazian, Francesca Caleri, Maria Rachele Bianchi, Patrizia Rossi, Eleonora Virgilio, Marco Capobianco, Rosa Cortese, Carla Tortorella, Francesca Rossi, Giovanna De Luca, Anna Perelli, Silvia Bozzetti, Luigi Zuliani, Margherita Nosadini, Stefano Sartori, Laura Brambilla, Alberto Gajofatto, Alberto Vogrig, Luca Massacesi, Valentina Damato, Matteo Gastaldi, and Sara Mariotto

How well do the new diagnostic criteria for MOGAD work in real-life clinical practice? Results from multi-center study in Italy


Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines

Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines

Journal: CNS Drugs; January 27, 2026

Author(s): Bassem Yamout, Riadh Gouider, Raed Al-Roughani, Salman Aljarallah, Nevine Shalaby, Jaber Al-Khabouri, Anu Jacob, Jihad Inshasi, Akram Mahdawi, Ahmed Shatila, Maya Zeineddine, Sarmad Al-Mashetah, Beatrice Canibano, Saeed Bohlega, Fatema Abdulla, Ilham Slassi, Aly Hassan, Sandra Ahmed, Magd Zakaria, Mohammed AlJumah, Yaser Al-Malik

How should NMOSD be diagnosed and treated in clinical practice? Guidelines for the Middle East and North Africa region


Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study

Journal: Neurology; July 30, 2025

Author(s): Jeffrey L Bennett, Kazuo Fujihara, Albert Saiz, Anthony L Traboulsee, Benjamin M Greenberg, Brian G Weinshenker, Francesco Patti, Ingo Kleiter, Jacqueline Palace, Jerome De Seze, Rachael Evans, Kathleen Blondeau, Gaëlle Klingelschmitt, Ivana Vodopivec, Masouda Rahim, Takashi Yamamura

How safe and effective is satralizumab over the long term in people with NMOSD?